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The structure of immunoglobulin superfamily domains 1 and 2
of MAdCAM-1 reveals novel features important for integrin
recognition
Kemin Tan1, Jose M Casasnovas2†, Jin-huan Liu1, Michael J Briskin3, 
Timothy A Springer2* and Jia-huai Wang1,4*
Background: Mucosal addressin cell adhesion molecule 1 (MAdCAM-1) is a
cell adhesion molecule that is expressed on the endothelium in mucosa, and
guides the specific homing of lymphocytes into mucosal tissues. MAdCAM-1
belongs to a subclass of the immunoglobulin superfamily (IgSF), the members
of which are ligands for integrins. Human MAdCAM-1 has a unique dual
function compared to other members in the same subclass in that it binds both
the integrin α4β7, through its two IgSF domains, and a selectin expressed on
leukocytes, via carbohydrate sidechains. The structure determination of the two
IgSF domains and comparison to the N-terminal two-domain structures of
vascular cell adhesion molecule 1 (VCAM-1) and intercellular adhesion
molecules (ICAM-1 and ICAM-2) allow us to assess the molecular basis of the
interactions between integrins and their preferred ligands.
Results:  The crystal structure of a fragment containing the two IgSF domains
of human MAdCAM-1 has been determined to 2.2 Å resolution. The structure of
MAdCAM-1 reveals two separate integrin-recognition motifs. The key integrin-
binding residue, Asp42, resides in the CD loop of domain 1; a buried arginine
residue (Arg70) plays a critical role in maintaining the conformation of this loop.
The second binding site is associated with an unusual long D strand in domain
2. The D and E strands extend beyond the main body of the domain, forming a
negatively charged β ribbon unique to MAdCAM-1. This ribbon is located on
the same face as the key aspartate residue in domain 1, consistent with
evidence that it is involved in integrin binding.
Conclusions: The structural comparison of MAdCAM-1 to other members of the
same IgSF subclass reveals some interesting features. Firstly, MAdCAM-1, like
VCAM-1, has the key integrin-binding residue located on the protruding CD loop
of domain 1 and binds to an integrin that lacks an I domain. This is in contrast to
ICAM-1 and ICAM-2 where the key residue is located at the end of the C strand
on a flat surface and which bind to integrins that contain I domains. Secondly,
architectural differences in the CD loops of MAdCAM-1 and VCAM-1 cause an
8 Å shift in position of the critical aspartate residue, and may partly determine their
binding preference for different integrins. Finally, the unusual charge distribution of
the two-domain fragment of MAdCAM-1 is predicted to orient the molecule
optimally for integrin binding on the top of its long mucin-like stalk.
Introduction
Cell adhesion molecules, including members of the
immunoglobulin superfamily (IgSF), the integrin family,
the selectin family and carbohydrate ligands for selectins,
have important roles in the immune response and immune
surveillance [1,2]. Ligands on the vascular endothelium
bind to receptors on blood leukocytes and signal the traf-
ficking of the immune system cells to sites of infection or
injury. The adhesion of leukocytes to endothelial cells [3]
and subsequent transendothelial migration [4] involves
multiple ‘receptor–ligand’ pairs. Binding of selectins to
carbohydrate ligands initiates the first step of adhesion
activity by mediating tethering of the leukocyte and tran-
sient adhesion to the vessel wall. These interactions permit
rolling of the cell along the vessel wall in response to hydro-
dynamic forces. The binding of the leukocyte β2 integrins
αLβ2 (LFA-1) and αMβ2 (Mac-1) to their ligands, which
include intercellular adhesion molecules (ICAM-1 and 2),
supports firm adhesion [1,5] and migration across the endo-
thelium into tissues. The leukocyte α4 integrins α4β1
(VLA-4) and α4β7 (LPAM-1) bind to their preferred
ligands, vascular cell adhesion molecule 1 (VCAM-1) and
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mucosal addressin cell adhesion molecule 1 (MAdCAM-1).
These molecules function at an intermediate stage in
leukocyte adhesion to the endothelium, namely they
support both rolling interaction and firm adhesion [6–8].
MAdCAM-1 is selectively expressed on high-endothelial
venules of Peyer’s patches, other gut associated lymphoid
tissues including appendix and mesenteric lymph nodes,
and in venules of the lamina propria [9,10]. The molecule
regulates traffic of a subset of lymphocytes into mucosal
tissues [2]. Human MAdCAM-1 contains, beginning from
its N terminus, two IgSF domains, a mucin-like region of
115 residues, a transmembrane domain, and a 43-residue
cytoplasmic domain [11]. MAdCAM-1 has a unique dual
function among cell adhesion molecules [8,12–15]: it binds
the integrin α4β7 through its IgSF domains, and when
appropriately O-glycosylated binds L-selectin through its
mucin-like region. The interaction with L-selectin medi-
ates a transient adhesion to the endothelium that allows the
cell to roll in response to hydrodynamic forces exerted on it
in the bloodstream. The interaction with α4β7 mediates
slower rolling and, after activation, firm adhesion.
MAdCAM-1, VCAM-1, ICAM-1 and ICAM-2 represent a
subclass of the IgSF that are specialized for binding to inte-
grins. These proteins can be recognized by their greater
amino acid sequence homology to one another than to other
IgSF members. The members of this subclass differ in their
specificities for integrins and the domains on integrins to
which they bind. For example, the N-terminal IgSF
domain of ICAM-1 and ICAM-2 binds to the I domain of
the integrin αLβ2, whereas the third IgSF domain of
ICAM-1 binds to the I domain of the integrin αMβ2. The
I domain is a domain of about 200 amino acids that is
inserted in the α subunit of some, but not all, integrins. In
those integrins in which it is present, the I domain plays
an important role in ligand binding. MAdCAM-1 and
VCAM-1 bind to the α4 integrins α4β7 and α4β1, respec-
tively. The α4 subunit lacks an I domain. Not only the
N-terminal IgSF domain of MAdCAM-1 and VCAM-1,
but also their second IgSF domain is involved in the inte-
grin interaction [16–18]. The similarities and differences
in these binding properties may reflect specializations in
these IgSF members and their integrin receptors.
Recently, the structures of the first two of five IgSF
domains of ICAM-1 and the entire extracellular portion of
ICAM-2 containing two IgSF domains have been deter-
mined by X-ray crystallography [19–21]. Together with the
structure of the first two domains of VCAM-1 [22,23], they
have revealed remarkable structural features of these cell
adhesion molecules, including the disposition of an acidic
residue in domain 1 (D1) that is critical for integrin recog-
nition. MAdCAM-1 is unique among the IgSF integrin
ligands in its specificity for α4β7. Furthermore, among this
IgSF subclass it alone is expressed on a long mucin-like
stalk and can bind to L-selectin. The amino acid sequence
of MAdCAM-1 has some unique features: a long acidic
insertion in domain 2 (D2), compared to D2 of VCAM-1;
an arginine residue predicted by homology to VCAM-1 to
be buried in the hydrophobic core of D1; and an unusually
high content of proline in D2 (12.3% compared to 5.1% in
average proteins) [24]. 
Here we describe the crystal structure of the N-terminal
fragment of human MAdCAM-1 containing the two IgSF
domains to 2.2 Å resolution. The structure shows some
remarkably distinctive aspects even compared to VCAM-1
[22,23], the most closely related IgSF family member with
23.5% amino acid sequence identity, and suggests novel
integrin-binding features.
Results and discussion
Structure determination
A fragment containing the two IgSF domains of human
MAdCAM-1 was expressed in lectin-resistant Chinese
hamster ovary (CHO) Lec.3.2.8.1 cells. The N-terminal
sequence Val-Lys-Pro-Leu revealed that the signal sequence
is 22 rather than 18 residues as previously predicted [11].
The fragment crystallized in space group C2221 with unit-
cell dimensions a = 65.8 Å, b = 101.1 Å, c = 70.0 Å and a
calculated solvent content of 50.1%. The structure was
determined using conventional multiple isomorphous
replacement methods and was refined with X-PLOR
(Table 1; [25]). The final R free and R factor are 0.280 and
0.223, respectively. The model contains 209 amino acid
residues, one N-acetyl glucosamine (NAG) residue and 77
water molecules. The only regions in the model that remain
weak in the electron-density map are residues 151–157 that
form a loop, and the five C-terminal residues 205–209 that
form the beginning of the mucin-like region. Of all the
residues, 92.3% are in the favored region of the Ramachan-
dran plot; only 3.6% are in the disallowed region and
occupy a special place in the structure, as discussed below.
Domain 1 and the key integrin-binding residue
The N-terminal IgSF domain (D1) of MAdCAM-1
(Figure 1) is small in size (90 residues). IgSF domains have
been previously classified into V, C1, C2 and I sets accord-
ing to edge strand content and key framework residues
[26]. The V and C1 sets of IgSF domain are so named based
on similarity to antibody V and C domains, respectively.
The V set consists of ABED strands on one β sheet and
A′GFCC′C′′ strands on the other β sheet, whereas the C1
set contains an ABED sheet and a GFC sheet. The C2 set
is a variation of the C1 set. It lacks a D strand, but contains
a normal C′ strand. The I set is an intermediate between
the V and C1 sets. It has an ABED sheet and an A′GFCC′
or A′GFC sheet. The I set has recently been subdivided
into I1 and I2 sets, analogous to the C1 and C2 division in
that the I1 set has a D strand whereas the I2 set does not
[20]. D1 of MAdCAM-1 may be classified as an I1 set,
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although it lacks a C′ strand. The A strand of D1 runs about
half way down the edge of the ABE sheet, then crosses over
the edge of the β sandwich and joins the A′GFC sheet at a
kink which usually involves a cis-proline, as seen in the V
set Ig framework. There is a conserved intersheet disulfide
bond in the core of the domain. Furthermore, as in other
IgSF integrin ligands [20,22,23,26], there is an ‘extra’ disul-
fide bond between Cys26 in the BC loop and Cys76 at the
end of the F strand that consolidates the tip of the Ig
domain. The residue Asp42, that is of key importance for
integrin binding, is located in the CD loop [11,17,18]. The
C and D strands form an ‘edge’ of the domain, as they are
edge strands in the A′GFC and the ABED β sheets, respec-
tively. The sidechain of Asp42 points up so as to be free for
integrin binding.
In the case of VCAM-1, the critical integrin-binding residue
Asp40 is also located in the CD loop [22,23]. In contrast, in
the structures of ICAM-1 [20,21] and ICAM-2 [19] the key
integrin binding glutamate residue is located at the end of
the C strand on a rather flat surface. The aspartate residues
in the CD loops of VCAM-1 and MAdCAM-1 are located in
a kink that may be considered a vestige of the C′ strand
found in some of the I1 set domains. There is no such
vestige of C′ strand in ICAM-1 or ICAM-2. Thus, the struc-
tural environments around the acidic residue in VCAM-1
and MAdCAM-1 are distinct from those in ICAM-1 and
ICAM-2. These differences correlate with binding to α4
integrins, that lack I domains, and to the integrin LFA-1
that does contain an I domain. There is, however, a key
distinction even between the integrin recognition motifs
in MAdCAM-1 and VCAM-1. In the overall super-
position of D1 of MAdCAM-1 and VCAM-1, Asp42 in
MAdCAM-1 and Asp40 in VCAM-1 lie 8 Å apart (Figures
2 and 3a; 53 of 90 residues gave a root mean square devia-
tion [rmsd] = 1.35 Å). The aspartate residue is also less pro-
truded in MAdCAM-1. These differences appear to be a
consequence of the two-residue deletion in the CD loop of
MAdCAM-1 compared to VCAM-1, and mainchain hydro-
gen bonds to Arg70 discussed below. If five-residue frag-
ments centered at the critical aspartic acid residue are used
for the superposition, however, the local conformation of
this ‘W-shaped’ motif matches well (inset, Figure 3a). This
W-shaped motif ensures that the acidic sidechain of the
aspartate residue is markedly exposed for integrin binding,
and may be a key structural determinant for α4 integrin
binding. Furthermore, if the aspartate residues in the
W-shaped motifs of MAdCAM-1 and VCAM-1 occupy a
similar position in the integrin-binding site, then the
remainder of D1 would be oriented quite differently. This
may partly account for their preference for binding to α4β7
and α4β1 integrins, respectively.
A buried arginine residue
Arg70 plays a critical role in maintaining the conformation
of the CD loop of D1. This arginine is fully buried in the
domain and is surrounded by seven hydrophobic residues:
Leu23, Trp38, Leu57, Val59, Ala66, Val85 and Leu87
(Figure 3b). Arg70 is located two residues before the con-
served Cys68 on the F strand that forms the intersheet
disulfide bond (Figure 1). The density for the sidechain of
Arg70 was unambiguous even in the earliest electron-
density maps. There are no negatively charged groups in
the vicinity of Arg70 to neutralize its strong positive charge.
Instead, the guanido group is placed in an optimal position
to donate three hydrogen bonds to mainchain carbonyl
oxygens: one to Ala66 (2.7 Å) in the beginning of the
F strand, and the other two to Asp42 (2.5 Å) and Thr43
(2.6 Å) in the CD loop (Figure 3b). Buried, unneutralized
arginines are rare, but have previously been found to have a
structural role by forming multiple hydrogen bonds to
backbone carbonyl oxygens [27]. In the case of
MAdCAM-1, the hydrogen bonds to the two successive
carbonyl groups of Asp42 and Thr43 appear to constrain the
backbone to a γ-turn-like conformation around Asp42
(Figure 3b). The turn is characterized by a hydrogen bond
between the CO group of Leu41 and the NH group of
Thr43 forming a seven-membered ring. The hydrogen
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Table 1
X-ray data collection and phasing statistics for MAdCAM-1.
Data set Native Se-Met K2PtCl4 UO2Ac
Data collection
Resolution (Å) 2.2 3.2* 2.8 4.0
Reflections
total number 87,803 79,151 51,386 13,359
unique 10,955 3917 5949 2094
Completeness (%) 92.2 99.9 99.2 100.0
I/σ(I) 13.9 18.6 12.0 12.7
Rmerge (%)† 7.4 5.7 5.4 7.5
MIR phasing
Concentration (mM) 1 0.2
Soak time (days) 6 1.5
Number of sites 1 1 1
Riso (%)‡ 8.9 10.1 10.2
Rcullis (acentric)§ 0.84 0.88 0.90
Phasing power# 1.16 1.25 0.80
Figure of merit¶ 0.40
Model refinement
Resolution (Å) 15.0–2.2
Rwork (%) 22.3
Rfree (%) 28.0
Rms deviation bonds (Å) 0.012
Rms deviation angles (°) 2.087
*Data up to 3.5 Å were used for phasing.
†Rmerge = 100 ΣhΣi|Ιi(h) – < Ι(h) > | / ΣhΣΙi(h), where Ιi(h) and < Ι(h) >
are the ith and mean measurement of the intensity of reflection h.
‡Riso = Σ|Fph–Fp|/ΣFp, where Fph and Fp are the derivative and native
structure-factor amplitudes, respectively.
§Rcullis(Cullis R factor) = Σ||Fph±Fp|–Fh(calc)|/Σ|Fph±Fp|, where Fh(calc) is
the calculated heavy-atom structure factor amplitude.
#Phasing power = <Fh>/E, where <Fh> is the root mean square heavy-
atom structure-factor amplitude and E is the residual lack of closure
error. ¶Figure of merit is the mean probability of a phase being correct.
bond is weak, and barely within the allowed range, but this
is generally true for this kind of seven-membered ring, an
energetically less favorable conformation than the
ten-membered ring found in a β turn [28]. The dihedral
angles for the peptide segment of residues 42–44 are in the
disallowed region on the Ramachandran plot. In particular,
Asp42 has unusual mainchain dihedral angles (φ = 102° and
ψ = –69°). The positive value of φ reflects steric strain and
is often functionally relevant [28]. Arg70 not only helps to
form the γ-turn-like structure, but also holds the CD loop
and the EF loop of D1 together. These two structural ele-
ments define the integrin-binding region in D1, and thus
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Figure 1
Stereo view ribbon drawing of the N-terminal
two-domain fragment of human MAdCAM-1.
The key Asp42 sidechain in domain 1 (D1) is
shown in ball-and-stick representation with
oxygens in red.  Two loops involved in integrin
binding, the CD loop on D1 and the DE
β ribbon on domain 2 (D2) are highlighted in
yellow delineated with red. The disulfide
bonds and the N-acetylglucosamine (NAG)
sugar group are also drawn in ball-and-stick
form, in yellow and gray, respectively. Only the
first NAG unit has been identified (with high
B factors) whereas the others appear to be
disordered. Site-directed mutagenesis to
remove the glycosylation site found no
significant effect on integrin-binding affinity
(J Rosebrook, N Green, N Cochran, KT, J-hW,
TAS and MJB, unpublished data). Residue
Tyr90, the ‘pivot’ between D1 and D2 is
shown in gray; a short piece of helix in D1 is
shown in blue. (The figure was prepared using
the program MOLSCRIPT [45].)
Figure 2
Structural alignment of the MAdCAM-1 and VCAM-1 amino acid
sequences. Structures were aligned with defaults of 3DMALIGN in
MODELLER [46]. The β strands defined by the program DSSP [47]
are shown with blue lines. The W-shaped binding motifs in both
MAdCAM-1 and VCAM-1 are highlighted in magenta. Residue Arg70
is shown in red and the DE β ribbon of D2 of MAdCAM-1 is
highlighted in purple. The acidic residues in the mucin-like domain of
MAdCAM-1 are shown in red; one ‘O’ is drawn in red beneath each
predicted O-linked site [48]. (The figure was prepared using the
program MOLSCRIPT [45].)
Arg70 has a key role in their conformation. Indeed, site-
directed mutagenesis has recently shown that substitution
of Arg70 with alanine abolishes integrin binding (J Rose-
brook, N Green, N Cochran, KT, J-hW, TAS and MJB,
unpublished data). In VCAM-1, a different type of elabo-
rate hydrogen-bond architecture, that includes a β-turn
hydrogen bond between Thr37 and Asp40, defines the
local conformation of the integrin-binding loop [23].
Domain 2 and the hydrophobic interface between domains
D2 of MAdCAM-1 is unique compared to D2 of other
known IgSF integrin ligands in that it contains a D strand
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Figure 3
Superposition of domains 1 and 2 of
MAdCAM-1 and VCAM-1 and the local
environment of residue Arg70 in MAdCAM-1.
(a) Stereo view superposition of D1 of
MAdCAM-1 (blue) and VCAM-1 (red). The
key integrin-binding residues, Asp42 in
MAdCAM-1 and Asp40 in VCAM-1, are
labeled. The structures were aligned as
described in the text. Inset: a local
superposition centered at the key aspartate
residues from the two molecules, showing
their common W-shaped binding structural
motifs. (b) Stereo view of the environment of
residue Arg70 of MAdCAM-1 (dark blue) and
its hydrogen bonds (purple dashed lines) to
three mainchain carbonyl oxygens. For clarity,
only five out of the seven hydrophobic
residues surrounding Arg70 are shown here
(in yellow), and strands D and E are truncated.
The γ-turn-like element centered at Asp42 is
illustrated. (c) Stereo view superposition of
D2 of MAdCAM-1 (blue) and VCAM-1 (red).
The D strand and DE loop in MAdCAM-1, and
part of the C′ strand and C′E loop in VCAM-1
are shown in thicker lines for comparison.
(The figures were prepared using the program
MOLSCRIPT [45]).
and belongs to the I1 set (Figures 1, 2 and 3c). Domains
that lack a D strand were previously classified as belonging
to the C2 set [29]. C1 and C2 set domains lack an A′ strand,
whereas the D2s of ICAM-1, ICAM-2 and VCAM-1 contain
an A′ strand and a β-sheet framework that more closely
resembles the I set [26]; therefore, they have been classi-
fied as the defining members of the I2 set of Ig domains
[20]. With 114 residues, D2 of MAdCAM-1 is unusually
large for an I set domain (Figures 1 and 2).
The boundary between D1 and D2 occurs between Tyr90
and Ala91 in MAdCAM-1. Tyr90 is part of the G strand in
D1. Ala91 forms two mainchain hydrogen bonds to
Thr118 in the BC loop in D2 (2.7 Å and 3.2 Å with proper
geometry). After Thr118 there is a cis proline residue,
Pro119. The cis conformation of the proline favors the
hydrophobic interaction between its pyrrolidine ring and a
group of hydrophobic residues from both D1 and D2,
including Ala14, Met186 and Leu188. The homologous
residues at the beginning of D2 in VCAM-1, ICAM-1 and
ICAM-2 also form strong mainchain hydrogen bonds to
the BC loop. The structure of the BC loop, and the 
cis-proline that follows the hydrogen-bonded residue in
the BC loop, are conserved in all IgSF integrin ligands,
including four examples of the VCAM-1 molecule and
three examples of ICAM-1 that differ in the angle
between D1 and D2 [20–23]. There is only one
MAdCAM-1 molecule in the asymmetric unit of the
crystal studied here, and therefore no evidence for inter-
domain movement. Nevertheless, because the domain
interface is predominantly hydrophobic in nature, we
predict that domain–domain movement should be possi-
ble. Furthermore, because of the conservation of the
hydrogen bond of Ala91 to the BC loop, we predict that if
movement does occur Tyr90 in MAdCAM-1 would act as
pivot similar to Tyr89 in VCAM-1 [30].
Distribution of proline residues and resistance to force at
the D2 junction with the mucin-like region
During leukocyte–endothelial adhesion in the vasculature,
tensile force, which can denature IgSF domains [31–33],
will be exerted on MAdCAM-1. Force can be distributed
over multiple β strands within a domain, and over multiple
contacts between IgSF domains. The boundary of D2 with
the mucin-like domain in MAdCAM-1 is likely to be the
most susceptible region to force, as the entire force would
be exerted on the end of strand G at the bottom of D2. D2
of MAdCAM-1 has several specialized features that appear
to allow it to resist this force, however. As D2 belongs to the
I set, β strand G is not an edge strand, but has backbone
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Figure 4
The distribution of proline residues in MAdCAM-1 and a predicted
orientation of the molecule. (a) Stereo view of the distribution of
proline residues in MAdCAM-1. The Cα atom of each proline is
highlighted in red. The figure was prepared using the program
MOLSCRIPT [45]. (b) Electrostatic potential surface representation of
the two N-terminal domains of MAdCAM-1 (blue, positive; red,
negative). The figure was prepared using the program GRASP [49].
hydrogen bonds on one side to strand F and on the other
side to strand A′. Notably, the I set IgSF domains of the
muscle proteins twitchin and titin, which function to resist
tensile stress, have the same characteristics [34,35]. Multi-
ple IgSF domains in the nervous system adhesion mol-
ecules NCAM and L1 are also known, or predicted, to
belong to the I set and have the A–A′ kink [30]. D2 of
MAdCAM-1 has an unusually high proline content (12.3%
compared to 5.1% for average proteins) [24]; these prolines
are concentrated on the bottom of D2 (Figure 3a). The
proline residues are predicted to add rigidity, and buttress
the bottom of D2 against the force applied to the end of the
G strand during adhesion to integrins.
The unusual negatively charged DE b ribbon of D2
The most striking structural feature of MAdCAM-1 is a
negatively charged DE β ribbon that extends from the D
and E strands of D2 (Figures 1 and 4). Seven of the 11
residues of this extension, from position 149–159, are
glutamate or aspartate residues. Mutation of residues
Glu148, Glu151, Glu152, or Glu157 to alanine diminishes
binding of α4β7 (J Rosebrook, N Green, N Cochran, KT,
J-hW, TAS and MJB, unpublished data). Deletion of
residues 143–150 also abolishes binding to α4β7 [17],
however, this deletion almost certainly disrupts D2 as it
removes four residues of strand D. Residues 149–159
extend 20 Å from the main body of D2, and have a con-
formation and twist like a slightly ‘unzipped’ β ribbon.
The B factors of these residues are high, indicating that
this extension is mobile. The DE extension may func-
tion to electrostatically orient the MAdCAM-1 integrin-
binding face. ICAM-2 has been proposed to be oriented
by tripod-like carbohydrates that are N-linked near the
base of D2 [19]. In contrast, MAdCAM-1 extends far
above the membrane on a mucin-like stalk that contains
residues 205–319 immediately following D2. Electron
microscopic studies of proteins containing similar mucin-
like domains have shown that the mucin-like region has
an extended, rod-like shape with an extension on average
of 1.8–2.0 Å per residue [36]. The mucin-like domain of
human MAdCAM-1 is thus estimated to extend approxi-
mately 22 nM and present the integrin binding IgSF
domains well above the cell surface. The first segment of
the mucin-like domain, 65 residues immediately follow-
ing the second IgSF domain, contains 15 acidic residues
and no basic residues. As cell surfaces have a net nega-
tive charge, it is likely that repulsive electrostatic forces
make the mucin-like fragment point away from, and
roughly perpendicular to, the membrane. We propose that
the DE ribbon functions as a negatively charged ‘antenna’
to orient the IgSF domains. The Coulombic field estab-
lished by the cell surface and mucin-like region will repel
the antenna on D2, and orient it facing away from the cell
surface. This action is predicted to optimally orient D1
and D2 such that the key integrin-binding residue
(Asp42 in the CD loop) and the surrounding region of D1
and the DE β ribbon in D2 will both be well positioned
for interaction with integrins on other cells.
Asp42 in the CD loop on D1 and the DE loop in D2 are
positioned 20–30 Å away from one another on the same face
of MAdCAM-1 (Figure 1). The DE loop might increase the
on rate for binding to α4β7 by orienting MAdCAM-1 as
described above, and also by guiding docking of a positively
charged integrin domain onto MAdCAM-1. The DE loop
might also directly bind α4β7. In murine VCAM-1, residues
on the same face of D2 together with residues around the
CD loop in D1 contribute to binding to both α4β1 and
α4β7 [17]. Integrin binding to D1 and D2 in MAdCAM-1
and VCAM-1 could be analogous to binding of the α5β1
integrin to the Arg-Gly-Asp (RGD) motif in fibronectin
type III domain 10 of fibronectin and to the ‘synergy
region’ in the neighboring domain 9 [37].
The preference of α4β1 for VCAM-1 and α4β7 for
MAdCAM-1 is mainly determined by the integrin β sub-
unit. We have identified two important differences between
VCAM-1 and MAdCAM-1: the orientation of the critical
aspartate residue in D1 with respect to the rest of D1; and
the presence of the DE antenna in D2 of MAdCAM-1.
Both regions bear residues that are important for recogni-
tion by the α4β7 integrin. Further work will be required to
determine the relative importance of these regions in inte-
grin specificity, and to establish which sites the integrin
α and β subunits bind.
Biological implications
Mucosal addressin cell adhesion molecule 1 (MAdCAM-1)
is a multifunctional adhesion molecule expressed on the
endothelium in mucosa. The molecule binds to receptors
on leukocytes in the bloodstream, enabling trafficking of
these immune cells to specific tissues. MAdCAM-1 is
capable of initiating primary lymphocyte contact at two
levels: to L-selectin, through its mucin-like region, as well
as to the integrin α4β7, through its immunoglobulin-like
(IgSF) domains. Furthermore, MAdCAM-1 binding to
integrin α4β7 can also mediate transient rolling adhesion.
MAdCAM-1 is the primary counter-receptor of integrin
α4β7, and regulates lymphocyte trafficking to both normal
and inflamed mucosal tissues. In vitro, pro-inflammatory
cytokines have been shown to induce the expression of
MAdCAM-1 on endothelium [38]. In addition, mono-
clonal antibodies to integrin α4β7 can block inflammatory
bowel disease, suggesting that the α4β7–MAdCAM-1
interaction has an important role in the inflammatory
process. Inhibition of MAdCAM-1 binding to integrin
α4β7 can control the inflammatory process and is there-
fore an attractive target for drug design [39,40].
The crystal structure of the two N-terminal IgSF
domains of MAdCAM-1 reveals many novel features
important for interaction with its integrin receptor.
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Comparison of MAdCAM-1 to other immunoglobulin
superfamily integrin ligands shows important similari-
ties and differences. These ligands share a similar overall
immunoglobulin-like topology and all have their critical
integrin-binding residues positioned at the edge of the first
IgSF domain (domain 1). Intercellular adhesion molecule
1 (ICAM-1) and ICAM-2 bind to I-domain-containing
integrins and have their key integrin-binding residues
located on a flat surface. In contrast, MAdCAM-1 and vas-
cular cell adhesion molecule 1 (VCAM-1) that bind to
non-I-domain-containing integrins have their key inte-
grin-binding residues located on protruding loops.
MAdCAM-1 and VCAM-1 both contain an aspartate
residue in domain 1 that is critical for integrin binding.
An overall structure superposition of these domains,
however, shows that this residue is shifted by 8 Å in the
two structures. This, together with a slight difference in
local conformation, may partly determine the specificity
of their integrin-binding abilities. Furthermore, dramatic
differences in structure between the domains 2 of
MAdCAM-1 and VCAM-1, including the presence of an
extended negatively charged β ribbon in MAdCAM-1,
provide an additional mechanism for determining integrin
specificity. The unique negatively charged β ribbon
stretches out far from the body of domain 2. The ribbon
may directly participate in integrin binding and help to
optimally orient domains 1 and 2 for recognition by inte-
grin during adhesion. 
Materials and methods
Protein expression and purification
A recombinant MAdCAM-1 cDNA with a translation stop codon in
position P232 of the precursor protein [11] was generated by the poly-
merase chain reaction (PCR) using Pfu DNA polymerase (Stratagene).
The recombinant fragment was subcloned into the unique Xho I and
Not I sites of the expression vector pBJ5/GS and used for transfection
of the lectin resistant CHO Lec.3.2.8.1 cell line [19]. Clones secreting
soluble recombinant MAdCAM-1 and growing in the presence of
100 µM L-methionine-sulfoximine were selected as described [19]. The
supernatant of selected cell clones collected in the presence of 2 mM
butyric acid was loaded on an anti-MAdCAM-1 antibody LS46
sepharose column. The column was extensively washed with 10 mM
Tris-saline buffer (pH 8.0) and the protein eluted with five column
volumes of 50 mM glycine-saline buffer (pH 3.2). Neutralized fractions
containing the recombinant MAdCAM-1 were pooled and run through
a Superdex 75 column (Pharmacia) with 10 mM Hepes buffer (pH 7.4).
The purified protein was analyzed by SDS–PAGE and concentrated to
about 17 mg/ml for crystallization. For preparation of the selenomethio-
nine MAdCAM-1 derivative, CHO cell transfectants were grown in a
Nunc Cell Factory device. Confluent cells were cultured for 10 h with
Dulbecco’s modified Engle’s medium (DMEM) lacking glutamine and
methionine, supplemented with 10% fetal calf serum (FCS) and con-
taining 50 µg/ml of seleno-L-methionine (Sigma) for depletion of intra-
cellular methionine. Culture medium was then replaced with the same
medium and the supernatant was collected three days later for purifica-
tion. The MAdCAM-1 protein concentration in the cell supernatant was
about 1 mg/L and selenomethionine incorporation was around 90%, as
revealed by amino acid analysis.
Crystallization and data collection
The crystals were grown using the conventional hanging-drop vapor
diffusion method, with a crystallization solution containing 10% PEG 4K,
0.5 M Li2SO4 (pH 7.5–8.0). Each native and derivative X-ray diffraction
data set was collected from a single crystal at room temperature on a
18 cm MAR Research area detector equipped with Rigaku RU200
rotating-anode X-ray generator. The crystal used to collect native data
was about 0.3 × 0.4 × 0.6 mm in dimensions and the crystal-to-detector
distance was 85 mm. A total of 112° of data were collected with oscil-
lation angle 1° and 10 min exposure per frame. The experimental set-
ups for derivatives were varied depending on how far they diffracted.
Reflections of each data set were integrated and scaled using the pro-
grams DENZO and SCALEPACK [41]. Subsequent analyses were
performed using the CCP4 suite [42].  A summary of the data collec-
tion and processing statistics is presented in Table 1.
Structure determination and refinement
Initial phasing was achieved with selenomethionine-labeled MAdCAM-1.
Although there is only one Se site in the 23 kDa molecular mass and dif-
fraction data were collected at room temperature using an in-house X-ray
source, the isomorphous difference Patterson map calculated at 3.5 Å
resolution revealed a well resolved Se peak. The initial phases, though
not good enough for calculating an interpretable map, helped to solve
Pt and U derivatives using the difference Fourier technique. The heavy-
atom parameters of these three derivatives were refined together and the
multiple isomorphous replacement (MIR) phases were calculated to
2.8 Å resolution with the program MLPHARE [42] within the CCP4 suite.
The electron-density maps were improved with procedures of density
modification and phase extension to 2.2 Å using the program DM [43]
in the CCP4 suite. Only solvent flattening and histogram matching
were applied. The subsequently calculated electron-density map clearly
showed the two domains of the molecule and most of their β strands.
Some bulky sidechains which form the cores of the Ig domains were also
recognized. Examination of electron-density map and model building
were performed using the program O [44].
The initial model was built into a 2.5 Å map. Successive cycles of
phase combination, difference Fourier map calculation and model
rebuilding, allowed placement of about 70% of the polypeptide chain.
Positional refinement, individual B-factor refinement and simulated-
annealing refinement were carried out with X-PLOR using data to 2.2 Å
[25], improving the structure progressively. Alternate model building
and refinement eventually led to the completion of the structure. Only
peaks above 3σ in the Fo–Fc difference map and consistent with the
2Fo–Fc map were accepted as water molecules if their geometry met
the requirement of forming hydrogen bonds to protein atoms or previ-
ously placed water molecules.
Accession numbers
The atomic coordinates of the human MAdCAM-1 crystal structure
have been deposited with the Brookhaven Protein Data Bank with
accession number 1mad.
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